ERC Starting Grant · 2024
The goal of this project is to define neurological outcomes after eclampsia and to determine underlying pathophysiological pathways to eclampsia which will lead to new drugs for neuroprotection of the maternal brain. Preeclampsia and eclampsia are the most common causes of direct maternal death globally. Magnesium sulphate is the only treatment in use but it has serious side effects, only protects from seizures in 50% of cases and neuroprotection on longterm is not established. Women with eclampsia run an increased risk of longterm neurological sequelae but causality with the acute insult is not proven. There is an urgent need to understand this relationship and underlying…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.